nodes	percent_of_prediction	percent_of_DWPC	metapath
Dicyclomine—CYP1A1—Dacarbazine—sarcoma	0.479	1	CbGbCtD
Dicyclomine—Malaise—Dactinomycin—sarcoma	0.00226	0.00435	CcSEcCtD
Dicyclomine—Mental disorder—Vincristine—sarcoma	0.00226	0.00433	CcSEcCtD
Dicyclomine—Erythema—Mitoxantrone—sarcoma	0.00218	0.00419	CcSEcCtD
Dicyclomine—Hypertension—Thiotepa—sarcoma	0.00218	0.00419	CcSEcCtD
Dicyclomine—Injection site reaction—Doxorubicin—sarcoma	0.00214	0.00411	CcSEcCtD
Dicyclomine—Discomfort—Dactinomycin—sarcoma	0.00211	0.00405	CcSEcCtD
Dicyclomine—Confusional state—Thiotepa—sarcoma	0.00208	0.004	CcSEcCtD
Dicyclomine—Hypoaesthesia—Etoposide—sarcoma	0.00208	0.00399	CcSEcCtD
Dicyclomine—Agitation—Vincristine—sarcoma	0.00206	0.00396	CcSEcCtD
Dicyclomine—Vision blurred—Mitoxantrone—sarcoma	0.00206	0.00395	CcSEcCtD
Dicyclomine—Oedema—Dactinomycin—sarcoma	0.00205	0.00393	CcSEcCtD
Dicyclomine—Ill-defined disorder—Mitoxantrone—sarcoma	0.00203	0.00389	CcSEcCtD
Dicyclomine—Nervous system disorder—Thiotepa—sarcoma	0.00202	0.00389	CcSEcCtD
Dicyclomine—Tachycardia—Thiotepa—sarcoma	0.00201	0.00387	CcSEcCtD
Dicyclomine—Malaise—Mitoxantrone—sarcoma	0.00197	0.00378	CcSEcCtD
Dicyclomine—Anorexia—Thiotepa—sarcoma	0.00197	0.00378	CcSEcCtD
Dicyclomine—Thrombophlebitis—Epirubicin—sarcoma	0.00195	0.00375	CcSEcCtD
Dicyclomine—Anorexia—Dactinomycin—sarcoma	0.00195	0.00375	CcSEcCtD
Dicyclomine—Eye disorder—Etoposide—sarcoma	0.00195	0.00374	CcSEcCtD
Dicyclomine—Cardiac disorder—Etoposide—sarcoma	0.00194	0.00372	CcSEcCtD
Dicyclomine—Hypertension—Vincristine—sarcoma	0.00194	0.00372	CcSEcCtD
Dicyclomine—Hypertension—Mitoxantrone—sarcoma	0.00189	0.00362	CcSEcCtD
Dicyclomine—Immune system disorder—Etoposide—sarcoma	0.00189	0.00362	CcSEcCtD
Dicyclomine—Mediastinal disorder—Etoposide—sarcoma	0.00188	0.00361	CcSEcCtD
Dicyclomine—Paraesthesia—Thiotepa—sarcoma	0.00185	0.00356	CcSEcCtD
Dicyclomine—Discomfort—Mitoxantrone—sarcoma	0.00184	0.00353	CcSEcCtD
Dicyclomine—Somnolence—Thiotepa—sarcoma	0.00184	0.00352	CcSEcCtD
Dicyclomine—Oedema—Vincristine—sarcoma	0.00183	0.00351	CcSEcCtD
Dicyclomine—Anaphylactic shock—Vincristine—sarcoma	0.00183	0.00351	CcSEcCtD
Dicyclomine—Dyspepsia—Thiotepa—sarcoma	0.00182	0.00349	CcSEcCtD
Dicyclomine—Thrombophlebitis—Doxorubicin—sarcoma	0.00181	0.00347	CcSEcCtD
Dicyclomine—Confusional state—Mitoxantrone—sarcoma	0.0018	0.00345	CcSEcCtD
Dicyclomine—Nervous system disorder—Vincristine—sarcoma	0.0018	0.00345	CcSEcCtD
Dicyclomine—Decreased appetite—Thiotepa—sarcoma	0.00179	0.00344	CcSEcCtD
Dicyclomine—Anaphylactic shock—Mitoxantrone—sarcoma	0.00178	0.00342	CcSEcCtD
Dicyclomine—Oedema—Mitoxantrone—sarcoma	0.00178	0.00342	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Thiotepa—sarcoma	0.00178	0.00342	CcSEcCtD
Dicyclomine—Decreased appetite—Dactinomycin—sarcoma	0.00178	0.00342	CcSEcCtD
Dicyclomine—Fatigue—Thiotepa—sarcoma	0.00178	0.00342	CcSEcCtD
Dicyclomine—Fatigue—Dactinomycin—sarcoma	0.00177	0.00339	CcSEcCtD
Dicyclomine—Constipation—Thiotepa—sarcoma	0.00177	0.00339	CcSEcCtD
Dicyclomine—Pain—Thiotepa—sarcoma	0.00177	0.00339	CcSEcCtD
Dicyclomine—Shock—Mitoxantrone—sarcoma	0.00175	0.00337	CcSEcCtD
Dicyclomine—Pain—Dactinomycin—sarcoma	0.00175	0.00336	CcSEcCtD
Dicyclomine—Anorexia—Vincristine—sarcoma	0.00174	0.00335	CcSEcCtD
Dicyclomine—Tachycardia—Mitoxantrone—sarcoma	0.00174	0.00334	CcSEcCtD
Dicyclomine—Lethargy—Epirubicin—sarcoma	0.00173	0.00331	CcSEcCtD
Dicyclomine—Feeling abnormal—Thiotepa—sarcoma	0.0017	0.00327	CcSEcCtD
Dicyclomine—Anorexia—Mitoxantrone—sarcoma	0.0017	0.00326	CcSEcCtD
Dicyclomine—Diplopia—Epirubicin—sarcoma	0.00169	0.00325	CcSEcCtD
Dicyclomine—Feeling abnormal—Dactinomycin—sarcoma	0.00169	0.00324	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Thiotepa—sarcoma	0.00169	0.00324	CcSEcCtD
Dicyclomine—Ill-defined disorder—Etoposide—sarcoma	0.00169	0.00324	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Dactinomycin—sarcoma	0.00168	0.00322	CcSEcCtD
Dicyclomine—Affect lability—Epirubicin—sarcoma	0.00166	0.00319	CcSEcCtD
Dicyclomine—Insomnia—Vincristine—sarcoma	0.00166	0.00318	CcSEcCtD
Dicyclomine—Paraesthesia—Vincristine—sarcoma	0.00164	0.00315	CcSEcCtD
Dicyclomine—Urticaria—Thiotepa—sarcoma	0.00164	0.00315	CcSEcCtD
Dicyclomine—Malaise—Etoposide—sarcoma	0.00164	0.00314	CcSEcCtD
Dicyclomine—Face oedema—Epirubicin—sarcoma	0.00163	0.00313	CcSEcCtD
Dicyclomine—Abdominal pain—Thiotepa—sarcoma	0.00163	0.00313	CcSEcCtD
Dicyclomine—Abdominal pain—Dactinomycin—sarcoma	0.00162	0.00311	CcSEcCtD
Dicyclomine—Mood swings—Epirubicin—sarcoma	0.0016	0.00307	CcSEcCtD
Dicyclomine—Paraesthesia—Mitoxantrone—sarcoma	0.0016	0.00307	CcSEcCtD
Dicyclomine—Loss of consciousness—Etoposide—sarcoma	0.0016	0.00307	CcSEcCtD
Dicyclomine—Lethargy—Doxorubicin—sarcoma	0.0016	0.00306	CcSEcCtD
Dicyclomine—Decreased appetite—Vincristine—sarcoma	0.00159	0.00305	CcSEcCtD
Dicyclomine—Dyspnoea—Mitoxantrone—sarcoma	0.00159	0.00305	CcSEcCtD
Dicyclomine—Somnolence—Mitoxantrone—sarcoma	0.00158	0.00304	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Vincristine—sarcoma	0.00158	0.00303	CcSEcCtD
Dicyclomine—Fatigue—Vincristine—sarcoma	0.00158	0.00303	CcSEcCtD
Dicyclomine—Dyspepsia—Mitoxantrone—sarcoma	0.00157	0.00301	CcSEcCtD
Dicyclomine—Hypertension—Etoposide—sarcoma	0.00157	0.00301	CcSEcCtD
Dicyclomine—Pain—Vincristine—sarcoma	0.00157	0.003	CcSEcCtD
Dicyclomine—Constipation—Vincristine—sarcoma	0.00157	0.003	CcSEcCtD
Dicyclomine—Diplopia—Doxorubicin—sarcoma	0.00156	0.003	CcSEcCtD
Dicyclomine—Decreased appetite—Mitoxantrone—sarcoma	0.00155	0.00297	CcSEcCtD
Dicyclomine—Affect lability—Doxorubicin—sarcoma	0.00154	0.00296	CcSEcCtD
Dicyclomine—Fatigue—Mitoxantrone—sarcoma	0.00154	0.00295	CcSEcCtD
Dicyclomine—Discomfort—Etoposide—sarcoma	0.00153	0.00293	CcSEcCtD
Dicyclomine—Breast disorder—Epirubicin—sarcoma	0.00153	0.00293	CcSEcCtD
Dicyclomine—Pain—Mitoxantrone—sarcoma	0.00152	0.00293	CcSEcCtD
Dicyclomine—Constipation—Mitoxantrone—sarcoma	0.00152	0.00293	CcSEcCtD
Dicyclomine—Hypersensitivity—Thiotepa—sarcoma	0.00152	0.00292	CcSEcCtD
Dicyclomine—Face oedema—Doxorubicin—sarcoma	0.00151	0.0029	CcSEcCtD
Dicyclomine—Hypersensitivity—Dactinomycin—sarcoma	0.00151	0.0029	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Vincristine—sarcoma	0.0015	0.00287	CcSEcCtD
Dicyclomine—Confusional state—Etoposide—sarcoma	0.0015	0.00287	CcSEcCtD
Dicyclomine—Muscular weakness—Epirubicin—sarcoma	0.00149	0.00286	CcSEcCtD
Dicyclomine—Anaphylactic shock—Etoposide—sarcoma	0.00148	0.00285	CcSEcCtD
Dicyclomine—Mood swings—Doxorubicin—sarcoma	0.00148	0.00285	CcSEcCtD
Dicyclomine—Asthenia—Thiotepa—sarcoma	0.00148	0.00284	CcSEcCtD
Dicyclomine—Abdominal distension—Epirubicin—sarcoma	0.00147	0.00282	CcSEcCtD
Dicyclomine—Asthenia—Dactinomycin—sarcoma	0.00147	0.00282	CcSEcCtD
Dicyclomine—Feeling abnormal—Mitoxantrone—sarcoma	0.00147	0.00282	CcSEcCtD
Dicyclomine—Pruritus—Thiotepa—sarcoma	0.00146	0.0028	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00146	0.0028	CcSEcCtD
Dicyclomine—Tachycardia—Etoposide—sarcoma	0.00145	0.00278	CcSEcCtD
Dicyclomine—Abdominal pain—Vincristine—sarcoma	0.00145	0.00278	CcSEcCtD
Dicyclomine—Urticaria—Mitoxantrone—sarcoma	0.00142	0.00272	CcSEcCtD
Dicyclomine—Breast disorder—Doxorubicin—sarcoma	0.00141	0.00271	CcSEcCtD
Dicyclomine—Anorexia—Etoposide—sarcoma	0.00141	0.00271	CcSEcCtD
Dicyclomine—Abdominal pain—Mitoxantrone—sarcoma	0.00141	0.0027	CcSEcCtD
Dicyclomine—Muscular weakness—Doxorubicin—sarcoma	0.00138	0.00265	CcSEcCtD
Dicyclomine—Dizziness—Thiotepa—sarcoma	0.00136	0.00262	CcSEcCtD
Dicyclomine—Abdominal distension—Doxorubicin—sarcoma	0.00136	0.00261	CcSEcCtD
Dicyclomine—Hypersensitivity—Vincristine—sarcoma	0.00135	0.00259	CcSEcCtD
Dicyclomine—Paraesthesia—Etoposide—sarcoma	0.00133	0.00256	CcSEcCtD
Dicyclomine—Dyspnoea—Etoposide—sarcoma	0.00132	0.00254	CcSEcCtD
Dicyclomine—Somnolence—Etoposide—sarcoma	0.00132	0.00253	CcSEcCtD
Dicyclomine—Hypersensitivity—Mitoxantrone—sarcoma	0.00131	0.00252	CcSEcCtD
Dicyclomine—Asthenia—Vincristine—sarcoma	0.00131	0.00252	CcSEcCtD
Dicyclomine—Vomiting—Thiotepa—sarcoma	0.00131	0.00252	CcSEcCtD
Dicyclomine—Drowsiness—Epirubicin—sarcoma	0.0013	0.0025	CcSEcCtD
Dicyclomine—Vomiting—Dactinomycin—sarcoma	0.0013	0.0025	CcSEcCtD
Dicyclomine—Rash—Thiotepa—sarcoma	0.0013	0.0025	CcSEcCtD
Dicyclomine—Dermatitis—Thiotepa—sarcoma	0.0013	0.0025	CcSEcCtD
Dicyclomine—Headache—Thiotepa—sarcoma	0.00129	0.00248	CcSEcCtD
Dicyclomine—Rash—Dactinomycin—sarcoma	0.00129	0.00248	CcSEcCtD
Dicyclomine—Decreased appetite—Etoposide—sarcoma	0.00129	0.00247	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Etoposide—sarcoma	0.00128	0.00246	CcSEcCtD
Dicyclomine—Asthenia—Mitoxantrone—sarcoma	0.00128	0.00245	CcSEcCtD
Dicyclomine—Fatigue—Etoposide—sarcoma	0.00128	0.00245	CcSEcCtD
Dicyclomine—Pain—Etoposide—sarcoma	0.00127	0.00243	CcSEcCtD
Dicyclomine—Constipation—Etoposide—sarcoma	0.00127	0.00243	CcSEcCtD
Dicyclomine—Nausea—Thiotepa—sarcoma	0.00123	0.00235	CcSEcCtD
Dicyclomine—Feeling abnormal—Etoposide—sarcoma	0.00122	0.00235	CcSEcCtD
Dicyclomine—Nausea—Dactinomycin—sarcoma	0.00122	0.00234	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Etoposide—sarcoma	0.00121	0.00233	CcSEcCtD
Dicyclomine—Dizziness—Vincristine—sarcoma	0.00121	0.00232	CcSEcCtD
Dicyclomine—Drowsiness—Doxorubicin—sarcoma	0.00121	0.00231	CcSEcCtD
Dicyclomine—Urticaria—Etoposide—sarcoma	0.00118	0.00226	CcSEcCtD
Dicyclomine—Abdominal pain—Etoposide—sarcoma	0.00117	0.00225	CcSEcCtD
Dicyclomine—Hypoaesthesia—Epirubicin—sarcoma	0.00116	0.00223	CcSEcCtD
Dicyclomine—Vomiting—Vincristine—sarcoma	0.00116	0.00223	CcSEcCtD
Dicyclomine—Rash—Vincristine—sarcoma	0.00115	0.00222	CcSEcCtD
Dicyclomine—Dermatitis—Vincristine—sarcoma	0.00115	0.00221	CcSEcCtD
Dicyclomine—Headache—Vincristine—sarcoma	0.00115	0.0022	CcSEcCtD
Dicyclomine—Vomiting—Mitoxantrone—sarcoma	0.00113	0.00218	CcSEcCtD
Dicyclomine—Rash—Mitoxantrone—sarcoma	0.00112	0.00216	CcSEcCtD
Dicyclomine—Dermatitis—Mitoxantrone—sarcoma	0.00112	0.00216	CcSEcCtD
Dicyclomine—Headache—Mitoxantrone—sarcoma	0.00112	0.00214	CcSEcCtD
Dicyclomine—Eye disorder—Epirubicin—sarcoma	0.00109	0.0021	CcSEcCtD
Dicyclomine—Hypersensitivity—Etoposide—sarcoma	0.00109	0.0021	CcSEcCtD
Dicyclomine—Nausea—Vincristine—sarcoma	0.00109	0.00209	CcSEcCtD
Dicyclomine—Cardiac disorder—Epirubicin—sarcoma	0.00109	0.00208	CcSEcCtD
Dicyclomine—Hypoaesthesia—Doxorubicin—sarcoma	0.00108	0.00207	CcSEcCtD
Dicyclomine—Asthenia—Etoposide—sarcoma	0.00106	0.00204	CcSEcCtD
Dicyclomine—Nausea—Mitoxantrone—sarcoma	0.00106	0.00203	CcSEcCtD
Dicyclomine—Immune system disorder—Epirubicin—sarcoma	0.00106	0.00203	CcSEcCtD
Dicyclomine—Mediastinal disorder—Epirubicin—sarcoma	0.00105	0.00202	CcSEcCtD
Dicyclomine—Pruritus—Etoposide—sarcoma	0.00105	0.00201	CcSEcCtD
Dicyclomine—Mental disorder—Epirubicin—sarcoma	0.00102	0.00197	CcSEcCtD
Dicyclomine—Erythema—Epirubicin—sarcoma	0.00102	0.00195	CcSEcCtD
Dicyclomine—Eye disorder—Doxorubicin—sarcoma	0.00101	0.00194	CcSEcCtD
Dicyclomine—Cardiac disorder—Doxorubicin—sarcoma	0.001	0.00193	CcSEcCtD
Dicyclomine—Tension—Epirubicin—sarcoma	0.000999	0.00192	CcSEcCtD
Dicyclomine—Nervousness—Epirubicin—sarcoma	0.000989	0.0019	CcSEcCtD
Dicyclomine—Dizziness—Etoposide—sarcoma	0.000981	0.00188	CcSEcCtD
Dicyclomine—Immune system disorder—Doxorubicin—sarcoma	0.000978	0.00188	CcSEcCtD
Dicyclomine—Mediastinal disorder—Doxorubicin—sarcoma	0.000976	0.00187	CcSEcCtD
Dicyclomine—Vision blurred—Epirubicin—sarcoma	0.00096	0.00184	CcSEcCtD
Dicyclomine—Mental disorder—Doxorubicin—sarcoma	0.000948	0.00182	CcSEcCtD
Dicyclomine—Ill-defined disorder—Epirubicin—sarcoma	0.000945	0.00181	CcSEcCtD
Dicyclomine—Vomiting—Etoposide—sarcoma	0.000943	0.00181	CcSEcCtD
Dicyclomine—Erythema—Doxorubicin—sarcoma	0.000942	0.00181	CcSEcCtD
Dicyclomine—Agitation—Epirubicin—sarcoma	0.000936	0.0018	CcSEcCtD
Dicyclomine—Rash—Etoposide—sarcoma	0.000935	0.00179	CcSEcCtD
Dicyclomine—Dermatitis—Etoposide—sarcoma	0.000934	0.00179	CcSEcCtD
Dicyclomine—Headache—Etoposide—sarcoma	0.000929	0.00178	CcSEcCtD
Dicyclomine—Tension—Doxorubicin—sarcoma	0.000925	0.00177	CcSEcCtD
Dicyclomine—Malaise—Epirubicin—sarcoma	0.000918	0.00176	CcSEcCtD
Dicyclomine—Nervousness—Doxorubicin—sarcoma	0.000915	0.00176	CcSEcCtD
Dicyclomine—Syncope—Epirubicin—sarcoma	0.000913	0.00175	CcSEcCtD
Dicyclomine—Palpitations—Epirubicin—sarcoma	0.0009	0.00173	CcSEcCtD
Dicyclomine—Loss of consciousness—Epirubicin—sarcoma	0.000895	0.00172	CcSEcCtD
Dicyclomine—Vision blurred—Doxorubicin—sarcoma	0.000888	0.0017	CcSEcCtD
Dicyclomine—Nausea—Etoposide—sarcoma	0.000881	0.00169	CcSEcCtD
Dicyclomine—Hypertension—Epirubicin—sarcoma	0.000879	0.00169	CcSEcCtD
Dicyclomine—Ill-defined disorder—Doxorubicin—sarcoma	0.000874	0.00168	CcSEcCtD
Dicyclomine—Agitation—Doxorubicin—sarcoma	0.000866	0.00166	CcSEcCtD
Dicyclomine—Discomfort—Epirubicin—sarcoma	0.000857	0.00164	CcSEcCtD
Dicyclomine—Malaise—Doxorubicin—sarcoma	0.00085	0.00163	CcSEcCtD
Dicyclomine—Dry mouth—Epirubicin—sarcoma	0.000848	0.00163	CcSEcCtD
Dicyclomine—Syncope—Doxorubicin—sarcoma	0.000845	0.00162	CcSEcCtD
Dicyclomine—Confusional state—Epirubicin—sarcoma	0.000838	0.00161	CcSEcCtD
Dicyclomine—Palpitations—Doxorubicin—sarcoma	0.000833	0.0016	CcSEcCtD
Dicyclomine—Anaphylactic shock—Epirubicin—sarcoma	0.000831	0.0016	CcSEcCtD
Dicyclomine—Oedema—Epirubicin—sarcoma	0.000831	0.0016	CcSEcCtD
Dicyclomine—Loss of consciousness—Doxorubicin—sarcoma	0.000828	0.00159	CcSEcCtD
Dicyclomine—Shock—Epirubicin—sarcoma	0.000818	0.00157	CcSEcCtD
Dicyclomine—Nervous system disorder—Epirubicin—sarcoma	0.000815	0.00156	CcSEcCtD
Dicyclomine—Hypertension—Doxorubicin—sarcoma	0.000814	0.00156	CcSEcCtD
Dicyclomine—Tachycardia—Epirubicin—sarcoma	0.000811	0.00156	CcSEcCtD
Dicyclomine—Discomfort—Doxorubicin—sarcoma	0.000793	0.00152	CcSEcCtD
Dicyclomine—Anorexia—Epirubicin—sarcoma	0.000792	0.00152	CcSEcCtD
Dicyclomine—Dry mouth—Doxorubicin—sarcoma	0.000785	0.00151	CcSEcCtD
Dicyclomine—Confusional state—Doxorubicin—sarcoma	0.000775	0.00149	CcSEcCtD
Dicyclomine—Oedema—Doxorubicin—sarcoma	0.000769	0.00148	CcSEcCtD
Dicyclomine—Anaphylactic shock—Doxorubicin—sarcoma	0.000769	0.00148	CcSEcCtD
Dicyclomine—Shock—Doxorubicin—sarcoma	0.000757	0.00145	CcSEcCtD
Dicyclomine—Nervous system disorder—Doxorubicin—sarcoma	0.000754	0.00145	CcSEcCtD
Dicyclomine—Insomnia—Epirubicin—sarcoma	0.000752	0.00144	CcSEcCtD
Dicyclomine—Tachycardia—Doxorubicin—sarcoma	0.000751	0.00144	CcSEcCtD
Dicyclomine—Paraesthesia—Epirubicin—sarcoma	0.000746	0.00143	CcSEcCtD
Dicyclomine—Dyspnoea—Epirubicin—sarcoma	0.000741	0.00142	CcSEcCtD
Dicyclomine—Somnolence—Epirubicin—sarcoma	0.000739	0.00142	CcSEcCtD
Dicyclomine—Anorexia—Doxorubicin—sarcoma	0.000733	0.00141	CcSEcCtD
Dicyclomine—Dyspepsia—Epirubicin—sarcoma	0.000732	0.0014	CcSEcCtD
Dicyclomine—Decreased appetite—Epirubicin—sarcoma	0.000723	0.00139	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Epirubicin—sarcoma	0.000718	0.00138	CcSEcCtD
Dicyclomine—Fatigue—Epirubicin—sarcoma	0.000717	0.00138	CcSEcCtD
Dicyclomine—Constipation—Epirubicin—sarcoma	0.000711	0.00136	CcSEcCtD
Dicyclomine—Pain—Epirubicin—sarcoma	0.000711	0.00136	CcSEcCtD
Dicyclomine—Insomnia—Doxorubicin—sarcoma	0.000696	0.00134	CcSEcCtD
Dicyclomine—Paraesthesia—Doxorubicin—sarcoma	0.000691	0.00133	CcSEcCtD
Dicyclomine—Dyspnoea—Doxorubicin—sarcoma	0.000686	0.00132	CcSEcCtD
Dicyclomine—Feeling abnormal—Epirubicin—sarcoma	0.000685	0.00131	CcSEcCtD
Dicyclomine—Somnolence—Doxorubicin—sarcoma	0.000684	0.00131	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Epirubicin—sarcoma	0.00068	0.0013	CcSEcCtD
Dicyclomine—Dyspepsia—Doxorubicin—sarcoma	0.000677	0.0013	CcSEcCtD
Dicyclomine—Decreased appetite—Doxorubicin—sarcoma	0.000669	0.00128	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000664	0.00127	CcSEcCtD
Dicyclomine—Fatigue—Doxorubicin—sarcoma	0.000663	0.00127	CcSEcCtD
Dicyclomine—Urticaria—Epirubicin—sarcoma	0.00066	0.00127	CcSEcCtD
Dicyclomine—Pain—Doxorubicin—sarcoma	0.000658	0.00126	CcSEcCtD
Dicyclomine—Constipation—Doxorubicin—sarcoma	0.000658	0.00126	CcSEcCtD
Dicyclomine—Abdominal pain—Epirubicin—sarcoma	0.000657	0.00126	CcSEcCtD
Dicyclomine—Feeling abnormal—Doxorubicin—sarcoma	0.000634	0.00122	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Doxorubicin—sarcoma	0.000629	0.00121	CcSEcCtD
Dicyclomine—Hypersensitivity—Epirubicin—sarcoma	0.000612	0.00118	CcSEcCtD
Dicyclomine—Urticaria—Doxorubicin—sarcoma	0.000611	0.00117	CcSEcCtD
Dicyclomine—Abdominal pain—Doxorubicin—sarcoma	0.000608	0.00117	CcSEcCtD
Dicyclomine—Asthenia—Epirubicin—sarcoma	0.000596	0.00114	CcSEcCtD
Dicyclomine—Pruritus—Epirubicin—sarcoma	0.000588	0.00113	CcSEcCtD
Dicyclomine—Hypersensitivity—Doxorubicin—sarcoma	0.000567	0.00109	CcSEcCtD
Dicyclomine—Asthenia—Doxorubicin—sarcoma	0.000552	0.00106	CcSEcCtD
Dicyclomine—Dizziness—Epirubicin—sarcoma	0.00055	0.00105	CcSEcCtD
Dicyclomine—Pruritus—Doxorubicin—sarcoma	0.000544	0.00104	CcSEcCtD
Dicyclomine—Vomiting—Epirubicin—sarcoma	0.000528	0.00101	CcSEcCtD
Dicyclomine—Rash—Epirubicin—sarcoma	0.000524	0.00101	CcSEcCtD
Dicyclomine—Dermatitis—Epirubicin—sarcoma	0.000524	0.001	CcSEcCtD
Dicyclomine—Headache—Epirubicin—sarcoma	0.000521	0.000999	CcSEcCtD
Dicyclomine—Dizziness—Doxorubicin—sarcoma	0.000509	0.000976	CcSEcCtD
Dicyclomine—Nausea—Epirubicin—sarcoma	0.000494	0.000948	CcSEcCtD
Dicyclomine—Vomiting—Doxorubicin—sarcoma	0.000489	0.000939	CcSEcCtD
Dicyclomine—Rash—Doxorubicin—sarcoma	0.000485	0.000931	CcSEcCtD
Dicyclomine—Dermatitis—Doxorubicin—sarcoma	0.000484	0.00093	CcSEcCtD
Dicyclomine—Headache—Doxorubicin—sarcoma	0.000482	0.000925	CcSEcCtD
Dicyclomine—Nausea—Doxorubicin—sarcoma	0.000457	0.000877	CcSEcCtD
